Wolfgang A. Herrmann

Wolfgang A. Herrmann's AcademicInfluence.com Rankings

Chemistry

#5340

World Rank

#6501

Historical Rank

chemistry Degrees

Wolfgang A. Herrmann

Biology

#14565

World Rank

#18345

Historical Rank

Neuroscience

#2569

World Rank

#2639

Historical Rank

Biochemistry

#2558

World Rank

#2727

Historical Rank

biology Degrees

Download Badge

Chemistry
Biology

Wolfgang A. Herrmann's Degrees

PhD Chemistry University of Regensburg

Why Is Wolfgang A. Herrmann Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Wolfgang A. Herrmann's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia (2006) (444)
Vitamin B-12 status, particularly holotranscobalamin II and methylmalonic acid concentrations, and hyperhomocysteinemia in vegetarians. (2003) (274)
DACH-LIGA Homocystein (German, Austrian and Swiss Homocysteine Society): Consensus Paper on the Rational Clinical Use of Homocysteine, Folic Acid and B-Vitamins in Cardiovascular and Thrombotic Diseases: Guidelines and Recommendations (2003) (254)
RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day. (1984) (217)
Independent elevations of N-terminal pro-brain natriuretic peptide and cardiac troponins in endurance athletes after prolonged strenuous exercise. (2005) (213)
Functional Vitamin B12 Deficiency and Determination of Holotranscobalamin in Populations at Risk (2003) (183)
Total homocysteine, vitamin B(12), and total antioxidant status in vegetarians. (2001) (172)
Homocysteine and lipids: S‐Adenosyl methionine as a key intermediate (2009) (153)
Causes and early diagnosis of vitamin B12 deficiency. (2008) (151)
[The effects of an antiprogesterone steroid in women: interruption of the menstrual cycle and of early pregnancy]. (1982) (149)
The Importance of Hyperhomocysteinemia as a Risk Factor for Diseases: An Overview (2001) (149)
The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases (2007) (126)
Increased osteoclast activity in the presence of increased homocysteine concentrations. (2005) (117)
Reproducibility and clinical significance of exercise-induced increases in cardiac troponins and N-terminal pro brain natriuretic peptide in endurance athletes (2006) (115)
The role of hyperhomocysteinemia as well as folate, vitamin B6 and B12 deficiencies in osteoporosis – a systematic review (2007) (115)
Vegetarian lifestyle and monitoring of vitamin B-12 status. (2002) (114)
Hyperhomocysteinaemia: a critical review of old and new aspects. (2007) (112)
Hyperhomocysteinemia in high-aged subjects: relation of B-vitamins, folic acid, renal function and the methylenetetrahydrofolate reductase mutation. (1999) (110)
Post-race kinetics of cardiac troponin T and I and N-terminal pro-brain natriuretic peptide in marathon runners. (2003) (108)
The usefulness of holotranscobalamin in predicting vitamin B12 status in different clinical settings. (2005) (108)
Telomere biology and age-related diseases (2018) (106)
Vitamin B12 status in the elderly as judged by available biochemical markers. (2004) (102)
Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases (2004) (102)
Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism. (2016) (96)
Intake of copper has no effect on cognition in patients with mild Alzheimer’s disease: a pilot phase 2 clinical trial (2008) (94)
Role of homocysteine, cystathionine and methylmalonic acid measurement for diagnosis of vitamin deficiency in high‐aged subjects (2000) (92)
Homocysteine – a newly recognised risk factor for osteoporosis (2005) (91)
The impact of vegetarianism on some haematological parameters (2002) (91)
Methylation status and neurodegenerative markers in Parkinson disease. (2009) (89)
Hyperhomocysteinemia induces a tissue specific accumulation of homocysteine in bone by collagen binding and adversely affects bone. (2009) (88)
Homocysteine Increases during Endurance Exercise (2003) (85)
Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer’s disease (2006) (83)
Cognitive decline correlates with low plasma concentrations of copper in patients with mild to moderate Alzheimer's disease. (2005) (83)
Quantification of acetylcholine, choline, betaine, and dimethylglycine in human plasma and urine using stable-isotope dilution ultra performance liquid chromatography-tandem mass spectrometry. (2010) (80)
Concentrations of unmetabolized folic acid and primary folate forms in pregnant women at delivery and in umbilical cord blood. (2010) (79)
Hyperhomocysteinemia: a new risk factor for degenerative diseases. (2002) (71)
Genetic Defects as Important Factors for Moderate Hyperhomocysteinemia (2001) (70)
Serum vitamin B12 not reflecting vitamin B12 status in patients with type 2 diabetes. (2013) (69)
Relation between homocysteine and biochemical bone turnover markers and bone mineral density in peri- and post-menopausal women (2005) (68)
Biomarkers of folate and vitamin B12 are related in blood and cerebrospinal fluid. (2007) (66)
A review of homocysteine and heart failure (2006) (65)
Simultaneous quantification of S-adenosyl methionine and S-adenosyl homocysteine in human plasma by stable-isotope dilution ultra performance liquid chromatography tandem mass spectrometry. (2009) (64)
Cobalamin deficiency. (2012) (63)
Disturbed homocysteine and methionine cycle intermediates S-adenosylhomocysteine and S-adenosylmethionine are related to degree of renal insufficiency in type 2 diabetes. (2005) (62)
Vitamins in the prevention of human diseases (2010) (59)
Stimulation of osteoclast activity by low B-vitamin concentrations. (2007) (59)
Folate and methylation status in relation to phosphorylated tau protein(181P) and beta-amyloid(1-42) in cerebrospinal fluid. (2007) (58)
Homocysteine, Cystathionine, Methylmalonic Acid and B-Vitamins in Patients with Renal Disease (2001) (58)
Comparison of the Influence of Volume-Oriented Training and High-Intensity Interval Training on Serum Homocysteine and Its Cofactors in Young, Healthy Swimmers (2003) (57)
Quantification of key folate forms in serum using stable-isotope dilution ultra performance liquid chromatography-tandem mass spectrometry. (2010) (57)
Biochemical indexes of the B vitamins in cord serum are predicted by maternal B vitamin status. (2005) (56)
Prevalences of hyperhomocysteinemia, unfavorable cholesterol profile and hypertension in European populations (2005) (55)
Effect of copper intake on CSF parameters in patients with mild Alzheimer’s disease: a pilot phase 2 clinical trial (2008) (55)
Response of homocysteine, cystathionine, and methylmalonic acid to vitamin treatment in dialysis patients. (2005) (54)
Experimental hyperhomocysteinemia reduces bone quality in rats. (2007) (54)
Holotranscobalamin in laboratory diagnosis of cobalamin deficiency compared to total cobalamin and methylmalonic acid (2007) (53)
The cobalamin-binding proteins transcobalamin and haptocorrin in maternal and cord blood sera at birth. (2006) (52)
The effect of B-vitamins on biochemical bone turnover markers and bone mineral density in osteoporotic patients: a 1-year double blind placebo controlled trial (2007) (52)
Significance of hyperhomocysteinemia. (2006) (51)
Homocysteine, folic acid and vitamin B12 in relation to pre- and postnatal health aspects (2005) (51)
Utility and limitations of biochemical markers of vitamin B12 deficiency (2013) (50)
Continuous Age-Dependent Reference Ranges for Thyroid Hormones in Neonates, Infants, Children and Adolescents Established Using the ADVIA(r) Centaur(tm) Analyzer (2002) (50)
Stimulation of osteoblast activity by homocysteine (2008) (48)
The vegetarian lifestyle and DNA methylation (2005) (48)
Relationship of plasma homocysteine with the severity of chronic heart failure. (2005) (47)
Concentrations of unmetabolized folic acid and primary folate forms in plasma after folic acid treatment in older adults. (2010) (47)
The Role of Genetic Factors in the Development of Hyperhomocysteinemia (2003) (46)
Markers of enhanced cholesterol absorption are a strong predictor for cardiovascular diseases in patients without diabetes mellitus. (2011) (46)
The mandatory fortification of staple foods with folic acid: a current controversy in Germany. (2011) (45)
The effect of endurance exercise-induced lactacidosis on biochemical markers of bone turnover (2007) (45)
Low serum vitamin B12 is associated with recurrent pregnancy loss in Syrian women (2008) (44)
Different kinetics of bone markers in normal and delayed fracture healing of long bones. (2002) (43)
Comparison of Procalcitonin, sCD14 and Interleukin-6 Values in Septic Patients (2000) (43)
Decreased p66Shc promoter methylation in patients with end-stage renal disease (2007) (42)
Homocysteine: a biomarker in neurodegenerative diseases (2011) (42)
The role of telomeres and vitamin D in cellular aging and age-related diseases (2015) (42)
Cellular Uptake of Vitamin B12 in Patients with Chronic Renal Failure (2005) (40)
Enhanced bone metabolism in vegetarians – the role of vitamin B12 deficiency (2009) (39)
No difference in N-terminal pro-brain natriuretic peptide (NT-proBNP) concentrations between endurance athletes with athlete’s heart and healthy untrained controls (2004) (39)
Plasma B vitamins and their relation to the severity of chronic heart failure. (2007) (37)
Reference standardization and triglyceride interference of a new homogeneous HDL-cholesterol assay compared with a former chemical precipitation assay. (1998) (36)
The emerging role of unmetabolized folic acid in human diseases: myth or reality? (2012) (36)
Low serum folate and vitamin B-6 are associated with an altered cancellous bone structure in humans. (2009) (36)
[Review of the role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric disorders--current evidence and preliminary recommendations]. (2007) (36)
Hyperhomocysteinemia and vitamin B-12 deficiency are more striking in Syrians than in Germans--causes and implications. (2003) (35)
Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study (2019) (34)
Effect of 1 year B and D vitamin supplementation on LINE-1 repetitive element methylation in older subjects (2013) (34)
Measurement of thiols in human plasma using liquid chromatography with precolumn derivatization and fluorescence detection. (1999) (34)
Concentrations of homocysteine, related metabolites and asymmetric dimethylarginine in preeclamptic women with poor nutritional status (2005) (34)
Plasma Homocysteine and Lipoprotein Profile in Patients with Peripheral Arterial Occlusive Disease (2000) (33)
Prospective study of telomere length and LINE-1 methylation in peripheral blood cells: the role of B vitamins supplementation (2016) (33)
Hyperhomocysteinemia Is Associated with Impaired Fracture Healing in Mice (2009) (32)
Folate supplementation does not affect biochemical markers of bone turnover. (2006) (31)
Biomarkers of folate and vitamin B12 status in cerebrospinal fluid (2007) (29)
Experimental Folate and Vitamin B12 Deficiency Does Not Alter Bone Quality in Rats (2009) (29)
Telomere length and mortality in the Ludwigshafen Risk and Cardiovascular Health study (2018) (29)
Hyperhomocysteinemia and response of methionine cycle intermediates to vitamin treatment in renal patients (2005) (27)
Plasma homocysteine levels & 677C-->T methylenetetrahydrofolate reductase gene polymorphism in patients with coronary artery disease of different severity. (2008) (27)
Homocysteine, brain natriuretic peptide and chronic heart failure: a critical review (2007) (27)
One year B and D vitamins supplementation improves metabolic bone markers (2013) (26)
The assessment of bone metabolism in female elite endurance athletes by biochemical bone markers (2004) (26)
Quantification of plasma phospholipids by ultra performance liquid chromatography tandem mass spectrometry (2011) (26)
Synergism between AT1 receptor and hyperhomocysteinemia during vascular remodeling (2007) (24)
Exercise-induced increases in NT-proBNP are not related to the exercise-induced immune response (2008) (24)
Homocysteine, Methylenetetrahydrofolate Reductase C677T Polymorphism and the B-Vitamins: A Facet of Nature-Nurture Interplay (2003) (24)
Blood biomarkers of methylation in Down syndrome and metabolic simulations using a mathematical model. (2012) (23)
Impairment of homocysteine metabolism in patients with retinal vascular occlusion and non-arteritic ischemic optic neuropathy (2005) (23)
One-carbon metabolites and telomere length in a prospective and randomized study of B- and/or D-vitamin supplementation (2017) (23)
Relationship of non-LDL-bound apo(a), urinary apo(a) fragments and plasma Lp(a) in patients with impaired renal function. (2003) (22)
Altered vitamin B12 status in recreational endurance athletes. (2005) (22)
Long-distance mountain biking does not disturb the measurement of total, free or complexed prostate-specific antigen in healthy men (2004) (22)
Deficiencies of folate and vitamin B12 do not affect fracture healing in mice. (2010) (21)
The Impact of Hyperhomocysteinemia as a Cardiovascular Risk Factor in the Prediction of Coronary Heart Disease (2003) (21)
Cobalamin status (holo-transcobalamin, methylmalonic acid) and folate as determinants of homocysteine concentration. (2002) (21)
Accumulation of homocysteine by decreasing concentrations of folate, vitamin B12 and B6 does not influence the activity of human osteoblasts in vitro. (2007) (20)
Assay of whole blood (6S)-5-CH3-H4folate using ultra performance liquid chromatography tandem mass spectrometry (2012) (19)
N-terminal B-type natriuretic peptide concentrations are similarly increased by 30 minutes of moderate and brisk walking in patients with coronary artery disease (2007) (19)
Alteration of homocysteine catabolism in pre-eclampsia, HELLP syndrome and placental insufficiency (2004) (19)
High bone concentrations of homocysteine are associated with altered bone morphology in humans. (2011) (19)
Folate is related to phosphorylated neurofilament‐H and P‐tau (Ser396) in rat brain (2011) (18)
Folic acid causes higher prevalence of detectable unmetabolized folic acid in serum than B-complex: a randomized trial (2016) (18)
Plasma trimethylamine‐N‐oxide following supplementation with vitamin D or D plus B vitamins (2017) (18)
Stimulatory Effect of Homocysteine on Interleukin-8 Expression in Human Endothelial Cells (2003) (18)
Relationship between Cytokine Concentrations (FGF, sICAM‐1 and SCF) in Serum, Follicular Fluid and ICSI Outcome (2004) (18)
Fluorescence‐based single‐strand conformation polymorphism analysis of mutations by capillary electrophoresis (2000) (17)
Fluorescence-based single-strand conformation polymorphism analysis of the low density lipoprotein receptor gene by capillary electrophoresis. (1999) (16)
An Increased Serum Level of Free Apo(a) in Renal Patients Is More Striking than that of Lp(a) and Is Influenced by Homocysteine (2000) (16)
Genetic defects in folate and cobalamin pathways affecting the brain (2012) (16)
Advanced glycation end products overload might explain intracellular cobalamin deficiency in renal dysfunction, diabetes and aging. (2011) (15)
Homocysteine in relation to C-reactive protein and low-density lipoprotein cholesterol in assessment of cardiovascular risk. (2004) (15)
Determination of Free Apolipoprotein(a) in Serum by Immunoassay and Its Significance for Risk Assessment in Patients with Coronary Artery Disease (1999) (15)
Progression of malignant melanoma is associated with reduced 25‐hydroxyvitamin D serum levels (2008) (14)
The Cardiac Effects of Prolonged Vitamin B12 and Folate Deficiency in Rats (2009) (14)
The measurement of complexed prostate-specific antigen has a better performance than total prostate-specific antigen (2004) (13)
Hyperhomocysteinemia is not associated with reduced bone quality in humans with hip osteoarthritis (2010) (13)
Hyperhomocysteinemia and myocardial expression of brain natriuretic peptide in rats. (2007) (13)
Apolipoprotein E2/E2 Genotype in Combination with Mutations in the LDL Receptor Gene Causes Type III Hyperlipoproteinemia (2002) (12)
The Importance of Telomere Shortening for Atherosclerosis and Mortality (2020) (11)
Sequential Changes and Pattern of Bone-Specific Alkaline Phosphatase after Trauma (2000) (11)
One year B-vitamins increases serum and whole blood folate forms and lowers plasma homocysteine in older Germans (2015) (11)
The Controversial Role of HCY and Vitamin B Deficiency in Cardiovascular Diseases (2022) (11)
The Risk of Venous Thromboembolism Associated with the Factor V Leiden Mutation and Low B-Vitamin Status (2003) (11)
Effect of folate supplementation on N-terminal pro-brain natriuretic peptide. (2007) (11)
Telomere length, vitamin B12 and mortality in persons undergoing coronary angiography: the Ludwigshafen risk and cardiovascular health study (2019) (10)
Effects of bunazosin and atenolol on serum lipids and apolipoproteins in a randomised trial. (1996) (10)
Factors affecting the distribution of folate forms in the serum of elderly German adults (2013) (10)
Trefoil factor family peptides in the human foetus and at birth (2011) (10)
Excess dietary methionine does not affect fracture healing in mice (2012) (9)
Letter re: “Elevated serum homocysteine and McKusick's hypothesis of a disturbed collagen cross-linking: What do we really know?” (2006) (9)
Homocysteine research: alive and kicking! (2007) (8)
Hyperhomocysteinemia--the biochemical link between a weak heart and brittle bones? (2006) (8)
Fluorescence-based SSCP analysis with automatic allele detection demonstrated for the factor V Leiden mutation. (1998) (8)
RU 486: studies of its antiglucocorticosteroid activity in man. (1985) (8)
In vitro inhibition of fibrinolysis by apolipoprotein(a) and lipoprotein(a) is size- and concentration-dependent (2004) (8)
Eight novel LDL receptor gene mutations among patients under LDL apheresis in Dresden and Leipzig (2001) (7)
Stability of serum β-crosslaps during storage : Influence of pH and storage temperature (2001) (7)
Cobalamin Analogues in Humans: A Study on Maternal and Cord Blood (2013) (7)
Aqueous humor glycation marker and plasma homocysteine in macular degeneration (2013) (7)
Re: "Elevated serum homocysteine and McKusick's hypothesis of a disturbed collagen cross-linking: What do we really know?". (2006) (6)
Stability of plasma homocysteine, S-adenosylmethionine, and S-adenosylhomocysteine in EDTA, acidic citrate, and Primavette collection tubes. (2007) (6)
Plasma 1‐carbon metabolites and academic achievement in 15‐yr‐old adolescents (2016) (5)
Biomarkers of neurodegenerative diseases (2011) (5)
Is hyperhomocysteinemia a risk factor for osteoporosis? (2008) (5)
[Body mass index, protein metabolism profiles and impact on IVF/ICSI procedure and outcome]. (2005) (5)
Folate therapy and in-stent restenosis. (2004) (5)
Comparison of two methods for measuring methylmalonic acid as a marker for vitamin B12 deficiency (2015) (5)
Homocysteine levels in patients treated with lipid apheresis: effect of a vitamin therapy (2001) (4)
Measurement of Serum β-Crosslaps Is Influenced by Proteolytic Conditions (2002) (4)
Homocysteine and cholesterol: guilt by association? (2009) (4)
Special issue on advances and controversies in B vitamins and choline (2013) (4)
Corrigendum to “Homocysteine and lipids: S‐Adenosyl methionine as a key intermediate” [FEBS Lett. 583 (2009) 1215–1225] (2009) (4)
Clinical validation of a new blood collection tube for the accuracy of total homocysteine measurement by different methods. (2007) (3)
[Hyperhomocysteinemia and B-vitamin deficiency. Current clinical aspects]. (2006) (3)
DACH-LIGA Homocystein (German, Austrian and Swiss Homocysteine Society): Consensus Paper on the Rational Clinical Use of Homocysteine, Folic Acid and B-Vitamins in Cardiovascular and Thrombotic Diseases: Guidelines and Recommendations (2004) (3)
Stability of serum beta-crosslaps during storage: influence of pH and storage temperature. (2001) (3)
[Effects of ovarian stimulation on serum concentrations of lipids and ketone bodies in patients undergoing IVF/ICSI treatment]. (2004) (3)
The clinical use of RU 486 (Mefipristone). (1989) (3)
Homocysteine research – where do we stand and where are we going? (2005) (3)
[Oral treatment of vitamin B12 deficiency in subacute combined degeneration]. (2006) (2)
Post-methionine-load hyperhomocysteinemia and increased lipoprotein(a) are associated with renal metabolic dysfunction: a hypothesis. (2002) (2)
Holotranscobalamin – An Early Marker for Laboratory Diagnosis of Vitamin B12 Deficiency (2009) (2)
Eight novel LDL receptor gene mutations among patients under LDL apheresis in Dresden and Leipzig. (2001) (2)
Genetic polymorphism of methylenetetrahydrofolate reductase (MTHFR) and coronary artery disease (2000) (2)
Mutation Analysis of Exon 3 of the LDL Receptor Gene in Patients with Severe Hypercholesterolemia (1998) (2)
[Clinical use of RU 486: control of the menstrual cycle and effect on the hypophyseal-adrenal axis]. (1983) (2)
Anaemia and Haemoglobinuria Holotranscobalamin – An Early Marker for Laboratory Diagnosis of Vitamin B 12 Deficiency (2014) (2)
Priorities in the discovery of the implications of water channels in epilepsy and Duchenne muscular dystrophy. (2006) (2)
Evaluation of alkaline phosphatase activity assay for the Reflotron system after substitution of the comparison method. (2005) (2)
43 – Vitamin B12 Deficiency in Vegetarians (2017) (2)
Changes in Markers of Bone Metabolism Following Surgery (2012) (1)
Vitamin B-12 status, particularly holotranscobalamin II and methylmalonic acid concentrations, and hyperhomocysteinemia (2003) (1)
2.P.273 The importance of hyperhomocysteinemia in high age people (1997) (1)
45 The importance of hyperhomocysteinemia in high age people (1997) (1)
Evaluation of the Current Evidence on Hyperhomocysteinaemia in Neurological Diseases (2008) (1)
Detection of Meningeosis neoplastica by real-time quantitation of telomerase activity (2009) (1)
Homocysteine-lowering Treatment in Reduction of Stroke and Coronary Vascular Risk - Do Not Give Up (2008) (1)
Measurement of serum beta-crosslaps is influenced by proteolytic conditions. (2002) (1)
Where Are We Standing in Homocysteine Research? (2003) (1)
[The effects of an antiprogesterone steroid in women: interruption of the menstrual cycle and of early pregnancy. Supplementary note]. (1983) (1)
[Venous thromboembolism in a young patient. Diagnosis: Retinal vein thromboembolism in mutation of the methylenetetrahydrofolate reductase gene]. (1999) (1)
The effect of the 677-MTHFR mutation on homocysteine level in elderly subjects and renal patients (2000) (1)
7 Vitamin B12 Cobalamin (2010) (1)
Functions and Deficiencies of B-Vitamins (and Their Prevention) (2008) (1)
The relationship between plasma free fatty acids, cognitive function and structural integrity of the brain in middle-aged healthy humans (2021) (1)
2.P.117 Is the measurement of unbound apo(a) of diagnostic interest (1997) (1)
Unbound apo(a) in patients with kidney disease (1999) (0)
Oral treatment of vitamin B12 deficiency proven effective in subacute combined degeneration (2005) (0)
Corrigendum to: The role of hyperhomocysteinemia as well as folate, vitamin B6 and B12 deficiencies in osteoporosis – a systematic review (2020) (0)
Bioavailability of slow-release co-dergocrine mesylate (dihydroergotoxine) formulations. (1987) (0)
Decreased p66Shc promoter methylation in patients and end-stage renal disease (2008) (0)
Bone alkaline phosphatase as a marker of fracture repair (1999) (0)
[Association between ovarian stimulation regime and protein metabolism of patients undergoing IVF/ICSI therapy]. (2003) (0)
Therapeutic Potential for Decreasing the Endogenous Toxin Homocysteine: Clinical Trials (2010) (0)
15 Omega-3 polyunsaturated fatty acids (fish oil) (2010) (0)
enzymes in the serum and modulate enzyme activity or interfere with the binding of polyclonal antibodies to the protein. The addition of polyclonal antibodies to cytosolic AST produced complete inhibition of the enzyme activity (2003) (0)
Homocysteine reduces bone quality by stimulation of osteoclasts (2008) (0)
1 History of the vitamins (2010) (0)
[Classification of hyperlipoproteinemias and interpretation of laboratory parameters]. (1994) (0)
PREANALYTICAL PROCESSING OF URINE SAMPLES FOR ENZYMUN-TEST BETA -CROSSLAPS (1998) (0)
Disturbed one-carbon metabolism in the central nervous system: implications for the pathogenesis of Alzheimer's disease (2006) (0)
The diagnostic value of homocysteine, methylmalonic acid and cystathionine in renal patients (2000) (0)
Acute negative inotropic effects of homocysteine are mediated via the endothelium (2004) (0)
57 Lipoprotein profile and homocystein in patients with peripheral arterial occlusive disease (1997) (0)
Erratum (2003) (0)
1.P.242 Influence of a LDL receptor gene defect on the expression of type III hyperlipoproteinemia (1997) (0)
4 Vitamin B2 Riboflavin (2010) (0)
Plasma homocyteine and lipoprotein profile in patients with peripheral arterial occlusive disease (1999) (0)
Historical Aspects and Perspectives in Homocysteine Research (2001) (0)
Co-dergocrine plasma concentrations and blood pressure changes in hypertensive patients during therapy with slow-release co-dergocrine mesylate. (1992) (0)
2P-0374 The D.A.CH.-LIGA homocysteine (German, Austrian and Swiss Homocysteine Society). Guidelines and recommendations on homocysteine measurement and use of folic acid and B-vitamins in cardiovascular and thrombotic disease (2003) (0)
Vitamin B-12 status , particularly holotranscobalamin II and methylmalonic acid concentrations , and hyperhomocysteinemia in vegetarians 1 – 3 (2003) (0)
8 Treatment with B-vitamins and disease outcome (2010) (0)
44 Is the measurement of unbound apo(a) of diagnostic interest (1997) (0)
Decrease in the risk of stroke by folic acid therapy. (2009) (0)
12 Vitamin K (2010) (0)
Increased prevalence of functionally deficient alleles of some proteins of plasma enzyme systems in severe CHD patients with previous myocardial infarction (1999) (0)
Hyperhomocysteinemia increases bone fragility and reduces osteoblast activity in adult wistar rats (2006) (0)
Comparison of two methods for measuring methylmalonic acid as a marker for vitamin B 12 deficiency (2015) (0)
Table 1. Genotypic information of parental WBCs and maternal plasma, based on five STR markers specific for 10q, obtained by fluorescent PCR assays in three consecutive pregnancies. (2001) (0)
9 Vitamin C Ascorbic acid (2010) (0)
2 Vitamin A Retinol (2010) (0)
11 Vitamin E Alpha-tocopherol (2010) (0)
THE ROLE OF BONE ALKALINE PHOSPHATASE (BAP) AS A DIAGNOSTIC MARKER OF FRACTURE REPAIR (1998) (0)
2.P.272 Genetic risk factors in the elderly: Studies in the apolipoprotein E gene and in the methylenetetrahydrofolate reductase gene (1997) (0)
One carbon metabolites and telomere length in cross-sectional, prospective and randomized one year B-/D-Vitamin supplementation trials (2018) (0)
Fluorescence-based sscp analysis of the LDL receptor gene by capillary electrophoresis (1999) (0)
10 Vitamin D Cholecalciferol (2010) (0)
The relevancy of the determination of serum metabolites of the methionine metabolism in elderly subjects (1999) (0)
2.20 Quantification of blood folate forms using stable-isotope dilution ultra performance liquid chromatography tandem mass spectrometry (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Wolfgang A. Herrmann?

Wolfgang A. Herrmann is affiliated with the following schools:

Saarland University

Wolfgang A. Herrmann's Academic­Influence.com Rankings

Wolfgang A. Herrmann's Degrees

Why Is Wolfgang A. Herrmann Influential?

Wolfgang A. Herrmann's Published Works

Published Works

What Schools Are Affiliated With Wolfgang A. Herrmann?

Wolfgang A. Herrmann's AcademicInfluence.com Rankings